Electrolyte, acid‐base, and medication management with renal replacement therapy

Abstract Fluid and electrolyte homeostasis exhibited by the kidneys is a complex process that is challenging to regulate with artificial renal replacement therapy (RRT). RRT has been used as a treatment modality for electrolyte and acid‐base disturbances in patients with acute kidney injury and chronic kidney disease. This review highlights the management of electrolyte shifts, acid‐base disturbances, and medication considerations in RRT, with a focus on intermittent hemodialysis and continuous RTT in the inpatient setting.